⌘K
Loading ticker…
Innoviva, Inc. Common Stock · Healthcare · Pharmaceutical Products
As of 2026-06-26, Innoviva, Inc. Common Stock (INVA) has a 3-month relative strength percentile of 49 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 53. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 2.6%, relative volume 3.19×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
49 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
INVA is in a stage 2 uptrend, week 1. Currently in a 84-day base; basing ADR 2.7% (broad 2.7%). VCP detected: inconclusive. RS line below base-start high. Distance from 50d / 200d: 3.7% / 11.6%.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
INVA is held by 9 ETFs as of Mar 2026. Top owner: IJR at 0.11% weight, $99M notional. Top 3 carry $194M.
Top 9 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| IJRiShares Core S&P Small-Cap ETF | 0.11% | $99M |
| VTIVanguard Total Stock Market ETF | 0.00% | $52M |
| IWMiShares Russell 2000 ETF | 0.06% | $42M |
| VBVanguard Small Cap ETF | 0.02% | $38M |
| VBRVanguard Small Cap Value ETF | 0.04% | $24M |
| VXFVanguard Extended Market ETF | 0.02% | $18M |
| IWOiShares Russell 2000 Growth ETF | 0.10% | $12M |
| XPHState Street SPDR S&P Pharmaceuticals ETF | 1.99% | $6M |
| ITOTiShares Core S&P Total U.S. Stock Market ETF | 0.00% | $2M |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | INVA Jan avg: 0.99% median: 0.52% win: 75% σ: 4.93% n: 4 2022-04-12 → 2026-05-29 | INVA Feb avg: 0.17% median: -4.22% win: 25% σ: 9.78% n: 4 2022-04-12 → 2026-05-29 | INVA Mar avg: -1.10% median: 0.46% win: 50% σ: 3.87% n: 4 2022-04-12 → 2026-05-29 | INVA Apr avg: -1.15% median: -0.85% win: 40% σ: 5.97% n: 5 2022-04-12 → 2026-05-29 | INVA May avg: 1.26% median: 4.50% win: 60% σ: 10.36% n: 5 2022-04-12 → 2026-05-29 | INVA Jun avg: -0.45% median: -0.02% win: 50% σ: 4.48% n: 4 2022-04-12 → 2026-05-29 (current) | INVA Jul avg: 2.23% median: 1.80% win: 50% σ: 10.68% n: 4 2022-04-12 → 2026-05-29 | INVA Aug avg: 0.29% median: -1.52% win: 50% σ: 9.40% n: 4 2022-04-12 → 2026-05-29 | INVA Sep avg: -5.23% median: -5.52% win: 25% σ: 6.99% n: 4 2022-04-12 → 2026-05-29 | INVA Oct avg: 3.34% median: 0.51% win: 50% σ: 9.30% n: 4 2022-04-12 → 2026-05-29 | INVA Nov avg: 6.23% median: 4.35% win: 50% σ: 11.17% n: 4 2022-04-12 → 2026-05-29 | INVA Dec avg: 0.02% median: -3.55% win: 50% σ: 11.39% n: 4 2022-04-12 → 2026-05-29 |